Connect with us

Research Reports

Organ Perfusion System Market Size To Reach USD 1.46 Billion By 2026 – Reports and Data

High demand for organ transplantation, increased awareness of organ donation, increase in the number of registered donors, prevailing cardiovascular and respiratory diseases and high investments in research in healthcare industry are key factors contributing to high CAGR of Organ Perfusion System during forecast period. According to the current analysis of Reports and Data, the global Organ…

The post Organ Perfusion System Market Size To Reach USD 1.46 Billion By 2026 – Reports and Data first appeared on News Degree | Hub for Latest and Trending News from Around the Globe.

gbaf1news

High demand for organ transplantation, increased awareness of organ donation, increase in the number of registered donors, prevailing cardiovascular and respiratory diseases and high investments in research in healthcare industry are key factors contributing to high CAGR of Organ Perfusion System during forecast period.

According to the current analysis of Reports and Data, the global Organ Perfusion System market was valued at USD 1.06 billion in 2018 and is expected to reach USD 1.46 billion by the year 2026, at a CAGR of 4.1%. Organ Perfusion Systems are used for storing the organs isolated from the donor’s body under a well-monitored environment to maintain the health of the organ before being transplanted into the receptor’s body. Most commonly perfused organs include the heart, kidney, liver, lungs, and others. Increasing prevalence of heart and respiratory diseases has led to an increase in the rates of organ failure. This is expected to drive the demand for organ transplantations. Rise in disposable income and changing lifestyle has led to an increase in heart disease cases while excessive alcohol consumption is increasing the rate of kidney failures, thus increasing the demand for kidney transplants. In addition, increasing awareness associated with organ donation has led to an increase in the number of registered organ donors. Increasing pharmaceutical research and growing investments in the new technologies is further expected to expand the market for organ perfusion system. Some strategies adopted by the major market players included joint ventures, partnerships, mergers & acquisitions, and the launch of new products. LivaNova, one of the leading providers of cardiovascular and neuromodulation solutions, designed a fifth-generation modular, heart-lunch machine, called cardiovascular S5, that provides higher standards for functionality, flexibility, and quality.

Since organ transplantation is the best way of saving the life of a patient with end-stage organ diseases, an increase in organ donation activities has led to the rise in the number of survivors of organ failure.  For example, Times Organs Donation Drive held in Mumbai, India, has led to a surge in organ donations, including cadaveric organ donation. Thus, growing awareness, increased organ transplantation, increased investments in research, and deployment of new technology in the healthcare sector is driving the growth of the organ perfusion system market. However, the lack of accessibility and expensive organ transplantation is expected to restrain the market during the forecast period.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2232

Further key findings from the report suggest

  • Organ Perfusion System market is growing at a CAGR of 5% in Asia Pacific followed by North America and Europe, with 4.2 % and 4.0% CAGR, respectively. High demand for organ transplantation is expected to drive the market for organ perfusion systems.
  • As of 2018, Hypothermic is the dominating Organ Perfusion System which holds 64.1% of the global market. North American regional market is the chief revenue generating source for this product segment, followed by Asia-Pacific and European regions
  • Presence of government initiatives such as National Organ transplant Programme and other non-profit organization such as Shatayu, Gift Your Organ, Multi Organ Transplantation and Human & Education Research (MOTHER) and many other organizations help in increasing the awareness of organ transplant.
  • Introduction of new technology like the living organ transplant that is capable of keeping the organ alive for a longer duration of time after being removed from the body offers new growth opportunities.
  • In order to maintain the health of the isolated organ, certain conditions and physiological parameters such as pH, pO2, pH and oxygen levels are required to be monitored. Some organs may require additional equipment and care based on their functions such as the isolated perfused lungs.
  • Innovative technology enables easy storage and transplantations of organ from one person to another with reduced risks. The Organ Care System (OCS) Heart, which preserves a donor’s heart in a near-normothermic environment in a beating state until it is replanted in the receptor’s body.
  • Growing government initiatives associated with organ donation and transplantation has eventually led to an increase in the number of organ transplantation cases. For example, Government of India enacted the Transplantation of Human Organs (Amendment) Act, for inclusion of grandchildren and grandparent in the ‘near relative’ category.
  • Additionally, several non-government organizations are working towards increasing the awareness related to the deaths caused by organ failure and educating the people for organ donation. For instance, Apex Kidney Foundation was set up to prevent kidney diseases by educating the people and through early detection.
  • A technology that enables the property of damage reversible is used for problematic organ transplantation like lungs. Only 20% of the lungs from a deceased donor is fit enough for transplantation, however, with the new technology ,the lungs are kept on physiological circuit and are continuously ventilated and perfused till the damage is recovered and the lungs are healthy enough to be transplanted.
  • Key participants include Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), and XENIOS AG (Germany), Lifeline Scientific, Inc. (U.S.), XVIVO Perfusion AB (Sweden), Repligen corporation and OrganOx.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2232

For the purpose of this report, Reports and Data has segmented the Organ Perfusion System market on the basis of type, organ type, technique type, component type, end use, and region:

Type (Revenue, USD Million; 2016–2026)

  • Bioreactors perfusion systems
  • Microfluidic perfusion systems
  • Pressure-driven perfusion systems

Organ Type (Revenue, USD Million; 2016–2026)

  • Heart
  • Lung
  • Liver
  • Kidney
  • Others

Technique Type (Revenue, USD Million; 2016–2026)

  • Hypothermic
  • Normothermic

Component Type (Revenue, USD Million; 2016–2026)

  • Perfusion Pumps
  • Oxygenators
  • Heart Lung Machine
  • Monitoring Systems
  • Cannulas
  • Others

End Use (Revenue, USD Million; 2016–2026)

  • Hospital
  • Clinic
  • Ambulatory Surgical Centers
  • Others

Regional Outlook (Revenue in USD Million; 2016–2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America
    • Brazil

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2232

Key Questions Answered by the Report:

  • What are the key growth driving and restraining factors of the Organ Perfusion System market?
  • What are key opportunities and growth prospects of the Organ Perfusion System industry is expected to witness over the forecast period?
  • Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
  • Which region is expected to dominate the market growth over the forecast period?
  • Which segments are expected to register lucrative growth over the forecast period?
  • What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis?

Thank you for reading our report. Please connect with us to know more about the report or for requesting customization of the report. Our team will ensure the report is best suited to meet your requirements.

Explore Reports and Data’s Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Peptide Synthesis Market @ https://www.google.kz/url?q=https://www.reportsanddata.com/report-detail/peptide-synthesis-market

Humanized Mouse Model Market @ https://www.google.cm/url?q=https://www.reportsanddata.com/report-detail/humanized-mouse-model-market

Human Liver Models Market @ https://www.google.com.et/url?q=https://www.reportsanddata.com/report-detail/human-liver-models-market

Vaccines Market @ https://www.google.kg/url?q=https://www.reportsanddata.com/report-detail/vaccines-market

Clinical Laboratory Tests Market @ https://www.google.co.zw/url?q=https://www.reportsanddata.com/report-detail/clinical-laboratory-tests-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]

Read Full Press Release: https://www.reportsanddata.com/press-release/global-organ-perfusion-system-market

The post Organ Perfusion System Market Size To Reach USD 1.46 Billion By 2026 – Reports and Data first appeared on News Degree | Hub for Latest and Trending News from Around the Globe.

Editorial & Advertiser disclosure
Our website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
Global Banking and Finance Review Awards Nominations 2021
2021 Awards now open. Click Here to Nominate

Recommended

Newsletters with Secrets & Analysis. Subscribe Now